Extract

The purpose of this study is to assess BAX 326 pharmacokinetic parameters, to evaluate its hemostatic efficacy, safety, immunogenicity, and changes in health-related quality of life in pediatric patients.

Inclusion criteria

• Hemophilia B

Country

• India
• Poland
• Romania
• Russian Federation
• Ukraine
• United Kingdom

Links

• nct
• ictrp